Publication

Pneumonia prevention during a humanitarian emergency: Cost-effectiveness of Haemophilus Influenzae Type B conjugate vaccine and pneumococcal conjugate vaccine in Somalia

Authored by:

Gargano L.M., Hajjeh R., and Cookson S.T.

Full Citation:

Gargano L.M., Hajjeh R., and Cookson S.T. 2015. Pneumonia prevention during a humanitarian emergency: Cost-effectiveness of Haemophilus Influenzae Type B conjugate vaccine and pneumococcal conjugate vaccine in Somalia. Prehospital and Disaster Medicine. 30(4).

View Publication

Additional key concepts from this publication:

Vaccines are a cost-effective means to reduce the high burden of pneumonia and diarrhea suffered by children living in humanitarian crisis settings.

Key Evidence: In a study modeling the cost-effectiveness of vaccination campaigns in Somalia – the country with the second largest number of refugees in 2012 – the use of Hib vaccine, PCV10, or both Hib and PCV10 were all found to be cost effective means to prevent excess morbidity and mortality from pneumonia in young Somali children. Such a vaccination campaign could conservatively reduce pneumonia cases and deaths by nearly 20%.